← Insider buys
APRE

Aprea Therapeutics, Inc. · Healthcare

Kdev Investments Ab sold $6.6M of Aprea Therapeutics, Inc.

10% owner

Sold$6,579,625
$31.25Price
210,548Shares
−9%Stake

What APRE did after the filing

Prices for APRE after this filing aren't in yet.

Traded Mon, Apr 13. Filed Wed, Apr 15, 5:18 AM ET, before the open. Not investment advice.